Physician profile
John Robert Green
NPI 1710447313
$18,456.93
in general payments reported to CMS, 2019-2025
11 companies · $12K in 2025
The $12K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $216 · 2024: $5,883 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $4,968 · Food and Beverage: $3,310 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $4,968.30 |
| Food and Beverage | $3,309.86 |
| Education | $178.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,000.00 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $5,537.56 | 2023-2025 | Oxford, Persona, Arcos Revision Hip Instrumentation |
| Stryker Corporation | $1,612.24 | 2023-2025 | Mako, Triathlon, Variax |
| Depuy Synthes Sales INC. | $569.95 | 2024-2025 | Na, Unium, Fibergraft Aeridyan Matrix |
| Medical Device Business Services, INC. | $232.06 | 2024 | |
| Orthalign INC | $197.80 | 2025 | Orthalign Plus |
| Davol INC. | $94.85 | 2024 | Arista Ah Flexitip |
| Medtronic, INC. | $85.30 | 2023 | Prestige LP Cervical Disc System |
| Elite Orthopedics, LLC | $67.15 | 2023-2024 | |
| Solventum Corporation | $38.77 | 2024-2025 | Prevena, V.A.C.Ulta, Activ.A.C. |
| Pacira Pharmaceuticals Incorporated | $21.25 | 2025 | Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.